NCT06389201View on ClinicalTrials.gov

Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 1, 2029

Study Completion Date

August 1, 2034

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

HCQ

HCQ, 400-600mg, oral tablet, once, one day before chemotherapy and radiotherapy. During therapy, HCQ maintenance dose is 200-400mg daily.

OTHER

Placebo

Placebo, oral tablet, once, one day before chemotherapy and radiotherapy. During therapy, placebo maintenance oral tablet once daily.

Trial Locations (1)

226000

RECRUITING

Bo You, Nantong

All Listed Sponsors
lead

Affiliated Hospital of Nantong University

OTHER